RIDGERO Trademark

Trademark Overview


On Friday, May 21, 2021, a trademark application was filed for RIDGERO with the United States Patent and Trademark Office. The USPTO has given the RIDGERO trademark a serial number of 79314843. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, February 26, 2024. This trademark is owned by NOVARTIS AG. The RIDGERO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
ridgero

General Information


Serial Number79314843
Word MarkRIDGERO
Filing DateFriday, May 21, 2021
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, February 26, 2024
Registration Number6617390
Registration DateTuesday, January 18, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 2, 2021

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, February 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Thursday, July 1, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Monday, July 12, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 20, 2021APPLICATION FILING RECEIPT MAILED
Monday, August 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 16, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 20, 2021ASSIGNED TO EXAMINER
Saturday, September 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, January 10, 2022ASSIGNED TO EXAMINER
Tuesday, January 18, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, February 17, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Monday, May 16, 2022FINAL DISPOSITION PROCESSED
Monday, May 16, 2022FINAL DISPOSITION NOTICE SENT TO IB
Sunday, June 12, 2022NOTIFICATION PROCESSED BY IB
Friday, September 20, 2024DEATH OF INTERNATIONAL REGISTRATION
Friday, September 20, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED